Sort by
Items per page

Send to

Choose Destination

Links from Protein

Items: 1 to 20 of 61


Jagged-2 enhances immunomodulatory activity in adipose derived mesenchymal stem cells.

Xishan Z, Bin Z, Haiyue Z, Xiaowei D, Jingwen B, Guojun Z.

Sci Rep. 2015 Sep 28;5:14284. doi: 10.1038/srep14284.


A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma.

Wang F, Remke M, Bhat K, Wong ET, Zhou S, Ramaswamy V, Dubuc A, Fonkem E, Salem S, Zhang H, Hsieh TC, O'Rourke ST, Wu L, Li DW, Hawkins C, Kohane IS, Wu JM, Wu M, Taylor MD, Wu E.

Oncotarget. 2015 Feb 20;6(5):2709-24.


The NOTCH ligand JAGGED2 promotes pancreatic cancer metastasis independent of NOTCH signaling activation.

Hu Y, Su H, Li X, Guo G, Cheng L, Qin R, Qing G, Liu H.

Mol Cancer Ther. 2015 Jan;14(1):289-97. doi: 10.1158/1535-7163.MCT-14-0501.


NOTCH1, NOTCH3, NOTCH4, and JAG2 protein levels in human endometrial cancer.

Sasnauskienė A, Jonušienė V, Krikštaponienė A, Butkytė S, Dabkevičienė D, Kanopienė D, Kazbarienė B, Didžiapetrienė J.

Medicina (Kaunas). 2014;50(1):14-8. doi: 10.1016/j.medici.2014.05.002.


Crosstalk between miR-34a and Notch Signaling Promotes Differentiation in Apical Papilla Stem Cells (SCAPs).

Sun F, Wan M, Xu X, Gao B, Zhou Y, Sun J, Cheng L, Klein OD, Zhou X, Zheng L.

J Dent Res. 2014 Jun;93(6):589-95. doi: 10.1177/0022034514531146.


Notch signaling genes: myogenic DNA hypomethylation and 5-hydroxymethylcytosine.

Terragni J, Zhang G, Sun Z, Pradhan S, Song L, Crawford GE, Lacey M, Ehrlich M.

Epigenetics. 2014 Jun;9(6):842-50. doi: 10.4161/epi.28597.


Targeting BMP9-promoted human osteosarcoma growth by inactivation of notch signaling.

Li R, Zhang W, Cui J, Shui W, Yin L, Wang Y, Zhang H, Wang N, Wu N, Nan G, Chen X, Wen S, Deng F, Zhang H, Zhou G, Liao Z, Zhang J, Zhang Q, Yan Z, Liu W, Zhang Z, Ye J, Deng Y, Luu HH, Haydon RC, He TC, Deng ZL.

Curr Cancer Drug Targets. 2014;14(3):274-85.


Activation of the NOTCH pathway in head and neck cancer.

Sun W, Gaykalova DA, Ochs MF, Mambo E, Arnaoutakis D, Liu Y, Loyo M, Agrawal N, Howard J, Li R, Ahn S, Fertig E, Sidransky D, Houghton J, Buddavarapu K, Sanford T, Choudhary A, Darden W, Adai A, Latham G, Bishop J, Sharma R, Westra WH, Hennessey P, Chung CH, Califano JA.

Cancer Res. 2014 Feb 15;74(4):1091-104. doi: 10.1158/0008-5472.CAN-13-1259.


High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.

Li W, Liu M, Feng Y, Huang YF, Xu YF, Che JP, Wang GC, Zheng JH.

Int J Clin Exp Pathol. 2013 Oct 15;6(11):2430-40.


A role for Jag2 in promoting uveal melanoma dissemination and growth.

Asnaghi L, Handa JT, Merbs SL, Harbour JW, Eberhart CG.

Invest Ophthalmol Vis Sci. 2013 Jan 9;54(1):295-306. doi: 10.1167/iovs.12-10209.


Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells.

Chiron D, Maïga S, Descamps G, Moreau P, Le Gouill S, Marionneau S, Ouiller T, Moreaux J, Klein B, Bataille R, Amiot M, Pellat-Deceunynck C.

Blood Cells Mol Dis. 2012 Apr 15;48(4):247-53. doi: 10.1016/j.bcmd.2012.01.006.


Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells.

Xing F, Okuda H, Watabe M, Kobayashi A, Pai SK, Liu W, Pandey PR, Fukuda K, Hirota S, Sugai T, Wakabayshi G, Koeda K, Kashiwaba M, Suzuki K, Chiba T, Endo M, Mo YY, Watabe K.

Oncogene. 2011 Sep 29;30(39):4075-86. doi: 10.1038/onc.2011.122.


JAG2 induction in hypoxic tumor cells alters Notch signaling and enhances endothelial cell tube formation.

Pietras A, von Stedingk K, Lindgren D, Påhlman S, Axelson H.

Mol Cancer Res. 2011 May;9(5):626-36. doi: 10.1158/1541-7786.MCR-10-0508.


Tumor necrosis factor-alpha and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation.

Fernandez L, Rodriguez S, Huang H, Chora A, Fernandes J, Mumaw C, Cruz E, Pollok K, Cristina F, Price JE, Ferkowicz MJ, Scadden DT, Clauss M, Cardoso AA, Carlesso N.

Exp Hematol. 2008 May;36(5):545-558. doi: 10.1016/j.exphem.2007.12.012.


Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines.

Houde C, Li Y, Song L, Barton K, Zhang Q, Godwin J, Nand S, Toor A, Alkan S, Smadja NV, Avet-Loiseau H, Lima CS, Miele L, Coignet LJ.

Blood. 2004 Dec 1;104(12):3697-704.


Characterization, chromosomal localization, and the complete 30-kb DNA sequence of the human Jagged2 (JAG2) gene.

Deng Y, Madan A, Banta AB, Friedman C, Trask BJ, Hood L, Li L.

Genomics. 2000 Jan 1;63(1):133-8.


NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma.

Fiaschetti G, Schroeder C, Castelletti D, Arcaro A, Westermann F, Baumgartner M, Shalaby T, Grotzer MA.

Acta Neuropathol Commun. 2014 Apr 7;2:39. doi: 10.1186/2051-5960-2-39.


Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells.

Hutter C, Kauer M, Simonitsch-Klupp I, Jug G, Schwentner R, Leitner J, Bock P, Steinberger P, Bauer W, Carlesso N, Minkov M, Gadner H, Stingl G, Kovar H, Kriehuber E.

Blood. 2012 Dec 20;120(26):5199-208. doi: 10.1182/blood-2012-02-410241.


[Expression and significance of Notch-1 and Jagged-2 in patients with Hirschsprung disease].

Jia HM, Han XF, Bai YZ, Wang WL.

Zhonghua Wei Chang Wai Ke Za Zhi. 2011 Oct;14(10):768-71. Chinese.


Downregulation of Notch-1/Jagged-2 in human colon tissues from Hirschsprung disease patients.

Jia H, Zhang K, Chen Q, Gao H, Wang W.

Int J Colorectal Dis. 2012 Jan;27(1):37-41. doi: 10.1007/s00384-011-1295-4.


Supplemental Content

Support Center